Aktive Wirkstoffe
- Ramucirumab
- ranibizumab
- ranolazine
- rasagiline
- rasagiline tartrate
- rasburicase
- ravulizumab
- reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain
- Reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
- Recombinant Adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain
- recombinant cholera toxin B subunit, vibrio cholerae 01
- recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live
- Recombinant human C1-inhibitor
- recombinant human n-acetylgalactosamine-6-sulfatase
- Recombinant human nerve growth factor
- recombinant inactivated avian influenza virus
- Recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP)
- recombinant omega interferon of feline origin
- Recombinant protein Q from Leishmania infantum MON-1
- Recombinant salmon calcitonin